These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4110298)

  • 1. Defined immunofluorescent staining: past progress, present status, and future prospects for defined conjugates.
    Beutner EH
    Ann N Y Acad Sci; 1971 Jun; 177():506-26. PubMed ID: 4110298
    [No Abstract]   [Full Text] [Related]  

  • 2. Field trials by ten laboratories of six commercial conjugates prepared from antisera to human IgG.
    Beutner EH
    Ann N Y Acad Sci; 1971 Jun; 177():361-404. PubMed ID: 4110296
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative studies of immunofluorescent staining. V. Analysis of unwanted staining of tissues.
    Andersen P; Nisengard R; Beutner EH
    Int Arch Allergy Appl Immunol; 1973; 45(4):479-87. PubMed ID: 4126852
    [No Abstract]   [Full Text] [Related]  

  • 4. Chessboard analyses with antinuclear antibodies.
    Hale WL; Bergquist R
    Ann N Y Acad Sci; 1971 Jun; 177():354-60. PubMed ID: 4110295
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects and problems in the definition and standardization of immunofluorescence. II. A quantitative assay for antibody protein of FITC-labeled anti-IgG conjugates.
    Huang JG; Beutner EH; Kumar V
    Ann N Y Acad Sci; 1983; 420():55-61. PubMed ID: 6372608
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the immunological specificity of fluorescein-labelled anti-human IgM conjugates.
    Chantler S; Haire M
    Immunology; 1972 Jul; 23(1):7-12. PubMed ID: 4114650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the standardization of antinuclear antibody (ANA) determination.
    ten Veen JH; Feltkamp TE
    Ann N Y Acad Sci; 1971 Jun; 177():346-53. PubMed ID: 4945670
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of immunological tests in routine synovial fluid analysis.
    Cracchiolo A; Barnett EV
    J Bone Joint Surg Am; 1972 Jun; 54(4):828-40. PubMed ID: 4341270
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of questions connected with the production of immunoglobulin preparations labelled with fluorescein isothiocyanate.
    Kiss I; Rásky K; Péterfy F
    Ann Immunol Hung; 1972; 16(0):243-8. PubMed ID: 4137516
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitation in immunofluorescence by radioimmunoassay.
    Johnson GD
    Ann N Y Acad Sci; 1971 Jun; 177():434-8. PubMed ID: 4945675
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood group substance A in carcinomas of the larynx.
    Dabelsteen E; Mygind N; Henriksen B
    Acta Otolaryngol; 1974 May; 77(5):360-7. PubMed ID: 4134201
    [No Abstract]   [Full Text] [Related]  

  • 12. Peroxidase conjugates for demonstration of tissue antibodies: evaluation of the technique.
    Petts V; Roitt IM
    Clin Exp Immunol; 1971 Sep; 9(3):407-18. PubMed ID: 4936875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of peroxidase-conjugated antiglobulin as an alternative to immunofluorescence for the detection of antinuclear factor in serum.
    Dorling J; Johnson GD; Webb JA; Smith ME
    J Clin Pathol; 1971 Sep; 24(6):501-5. PubMed ID: 4106192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescent detection of autoantibodies in the sera of acute infective hepatitis patients.
    Holborow EJ; Johnson GD; Farrow LJ; Zuckerman AJ; Taylor PE
    Ann N Y Acad Sci; 1971 Jun; 177():214-7. PubMed ID: 5003385
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects and problems in the definition and standardization of immunofluorescence. I. Present levels of reproducibility and disease specificity of antinuclear antibody tests.
    Beutner EH; Krasny S; Kumar V; Taylor R; Chorzelski TP
    Ann N Y Acad Sci; 1983; 420():28-54. PubMed ID: 6372596
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunopathology of lupus erythematosus: a comparison of immunohistochemical techniques. I. Immunofluorescence.
    Tuffanelli DL
    Adv Biol Skin; 1971; 11():287-94. PubMed ID: 4124142
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the solubility of immunoglobulins after fluorescent labeling and its influence on immunofluorescent techniques.
    Arnold W; von Mayersbach H
    J Histochem Cytochem; 1972 Dec; 20(12):975-85. PubMed ID: 4118359
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative evaluation of direct and indirect immunofluorescence tests for viral antigens.
    Espmark JA; Grandien M; Bergquist NR
    Ann N Y Acad Sci; 1971 Jun; 177():98-112. PubMed ID: 4110300
    [No Abstract]   [Full Text] [Related]  

  • 19. Photometric evaluation of indirect immunofluorescence chessboard titrations for the characterization of FITC-labelled antibodies.
    Albini B; Herzog F; Wick G
    Immunology; 1972 Sep; 23(3):343-54. PubMed ID: 4139109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies and immunocomplexes in Chagas' disease.
    Mosca W; Cedillos R
    Acta Cient Venez; 1988; 39(4):363-7. PubMed ID: 3152044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.